These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 8276066

  • 21. Behavioural effects in the rat of the putative dopamine D3 receptor agonist 7-OH-DPAT: comparison with quinpirole and apomorphine.
    Depoortere R, Perrault G, Sanger DJ.
    Psychopharmacology (Berl); 1996 Apr; 124(3):231-40. PubMed ID: 8740044
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Differential effects of 7-OH-DPAT on the development of behavioral sensitization to apomorphine and cocaine.
    Mattingly BA, Caudill A, Abel M.
    Pharmacol Biochem Behav; 2001 Mar; 68(3):417-26. PubMed ID: 11325394
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. 7-OH-DPAT injected into the accumbens reduces locomotion and sucrose ingestion: D3 autoreceptor-mediated effects?
    Gilbert DB, Cooper SJ.
    Pharmacol Biochem Behav; 1995 Oct; 52(2):275-80. PubMed ID: 8577791
    [Abstract] [Full Text] [Related]

  • 29. Dopamine agonist-induced yawning in rats: a dopamine D3 receptor-mediated behavior.
    Collins GT, Witkin JM, Newman AH, Svensson KA, Grundt P, Cao J, Woods JH.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):310-9. PubMed ID: 15833897
    [Abstract] [Full Text] [Related]

  • 30. Evidence that dopamine D3 receptors participate in clozapine-induced hypothermia.
    Millan MJ, Audinot V, Melon C, Newman-Tancredi A.
    Eur J Pharmacol; 1995 Jul 04; 280(2):225-9. PubMed ID: 7589191
    [Abstract] [Full Text] [Related]

  • 31. Evidence for the occurrence of depressant EEG effects after stimulation of dopamine D3 receptors: a computerized study in rabbits.
    Popoli P, Pèzzola A, Reggio R, Scotti de Carolis A.
    Life Sci; 1996 Jul 04; 59(21):1755-61. PubMed ID: 8937502
    [Abstract] [Full Text] [Related]

  • 32. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 04; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 33. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; jaw movements.
    Koshikawa N, Miwa Y, Adachi K, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):227-34. PubMed ID: 8858292
    [Abstract] [Full Text] [Related]

  • 34. Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat.
    Ahlenius S, Salmi P.
    Eur J Pharmacol; 1994 Aug 01; 260(2-3):177-81. PubMed ID: 7988642
    [Abstract] [Full Text] [Related]

  • 35. 7-OH-DPAT, unlike quinpirole, does not prime a yawning response in rats.
    Oswiecimska J, Brus R, Szkilnik R, Nowak P, Kostrzewa RM.
    Pharmacol Biochem Behav; 2000 Sep 01; 67(1):11-5. PubMed ID: 11113478
    [Abstract] [Full Text] [Related]

  • 36. The involvement of cerebellar dopamine D3 receptors in locomotor activity of rats.
    Kolasiewicz W, Maj J, Ossowska K.
    J Neural Transm (Vienna); 2008 May 01; 115(5):677-81. PubMed ID: 18188494
    [Abstract] [Full Text] [Related]

  • 37. The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
    Maj J, Rogóz Z, Skuza G.
    J Neural Transm (Vienna); 1999 May 01; 106(11-12):1063-73. PubMed ID: 10651103
    [Abstract] [Full Text] [Related]

  • 38. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning.
    Khroyan TV, Baker DA, Neisewander JL.
    Psychopharmacology (Berl); 1995 Dec 01; 122(4):351-7. PubMed ID: 8657832
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.